tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126

JW (Cayman) Therapeutics Co. Ltd. (2126) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
JW (Cayman) Therapeutics Co. Ltd.
HK$2.78
HK$1.17B
-1.71
113.85%
0 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$10.23
HK$9.97B
40.68
196.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.32
HK$9.89B
-45.83
57.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$5.48
HK$2.63B
-3.72
-31.50%
CStone Pharmaceuticals
HK$5.62
HK$8.17B
-18.58
126.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.71
HK$5.42B
140.94
0.11%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.78
1.43
105.93%
HK:9966
Alphamab Oncology
10.67
7.16
203.99%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.16
2.02
64.33%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.48
-2.52
-31.50%
HK:2616
CStone Pharmaceuticals
5.79
3.45
147.44%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.71
0.01
0.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts